XML 19 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Operations and Comprehensive Loss - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Costs and expenses:    
Research and development expense $ 5,418,706 $ 9,603,922
General and administrative expense 5,522,312 5,056,188
Total costs and expenses 10,941,018 14,660,110
Loss from operations (10,941,018) (14,660,110)
Interest income 581,668 7,069
Net loss and comprehensive loss $ (10,359,350) $ (14,653,041)
Basic net loss per common share (in dollars per share) $ (0.17) $ (0.28)
Diluted net loss per common share (in dollars per share) $ (0.17) $ (0.28)
Basic weighted-average number of common shares outstanding (in shares) 60,350,127 52,331,391
Diluted weighted-average number of common shares outstanding (in shares) 60,350,127 52,331,391